Edgewell Personal Care Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated February 5, 2026, covers the Company's 2026 Annual Meeting of Shareholders held on that date and the announcement of financial results for the first quarter of fiscal 2026, issued on February 9, 2026.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing Q1 fiscal 2026 results and supplemental recast financial information (Exhibit 99.2) for the fiscal year ended September 30, 2025. However, this specific 8-K text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the referenced exhibits for detailed financial data.
Material Changes and Corporate Actions
- Stock Incentive Plan Approval: Shareholders approved the 3rd Amended and Restated 2018 Stock Incentive Plan. This plan increases authorized shares by 2,100,000, eliminates the fungible share ratio for new awards, and removes provisions related to the repealed Section 162(m) exception.
- Recast Financials: The Company posted supplemental financial information recasting continuing and discontinued operations for the fiscal year ended September 30, 2025, and interim periods.
Shareholder Voting Results
Of 46,715,107 shares outstanding, 43,465,774 were represented at the Annual Meeting. Key voting outcomes include:
- Director Elections: All nine management nominees were elected. Notable dissent included Rod R. Little (6,227,585 votes against) and Rakesh Sachdev (3,675,126 votes against).
- Executive Compensation (Say-on-Pay): Approved with 31,787,030 votes for and 9,020,992 votes against.
- Stock Incentive Plan: Approved with 34,771,839 votes for and 6,061,275 votes against.
- Auditor Ratification: PricewaterhouseCoopers LLP was ratified with 42,715,456 votes for.
Outlook and Risks
The filing does not contain specific management commentary on future guidance, risks, or contingencies beyond the standard incorporation of the press release and supplemental financial data. The filing explicitly states that the information furnished under Items 2.02 and 7.01 is not "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 fiscal 2026 revenue, earnings, and margin figures.
- Examine Exhibit 99.2 for details on the recast financials regarding discontinued operations for fiscal 2025.
- Analyze the significant "Against" votes for directors Rod R. Little and Rakesh Sachdev to understand shareholder sentiment.
- Verify the impact of the 2,100,000 share increase in the Stock Incentive Plan on potential dilution.